share_log

Cantor Fitzgerald Reiterates Overweight on Mind Medicine, Maintains $7 Price Target

Benzinga ·  Aug 22, 2023 09:56

Cantor Fitzgerald analyst Charles Duncan reiterates Mind Medicine (NASDAQ:MNMD) with a Overweight and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment